238 related articles for article (PubMed ID: 21747140)
1. [Autoantibodies in thymoma-associated myasthenia gravis and their clinical significance].
Suzuki S
Brain Nerve; 2011 Jul; 63(7):705-12. PubMed ID: 21747140
[TBL] [Abstract][Full Text] [Related]
2. Classification of myasthenia gravis based on autoantibody status.
Suzuki S; Utsugisawa K; Nagane Y; Satoh T; Terayama Y; Suzuki N; Kuwana M
Arch Neurol; 2007 Aug; 64(8):1121-4. PubMed ID: 17698702
[TBL] [Abstract][Full Text] [Related]
3. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma.
Mygland A; Tysnes OB; Matre R; Volpe P; Aarli JA; Gilhus NE
Ann Neurol; 1992 Oct; 32(4):589-91. PubMed ID: 1333745
[TBL] [Abstract][Full Text] [Related]
4. Striational antibodies in myasthenia gravis: reactivity and possible clinical significance.
Romi F; Skeie GO; Gilhus NE; Aarli JA
Arch Neurol; 2005 Mar; 62(3):442-6. PubMed ID: 15767509
[TBL] [Abstract][Full Text] [Related]
5. Paraneoplastic IgG striational autoantibodies produced by clonal thymic B cells and in serum of patients with myasthenia gravis and thymoma react with titin.
Williams CL; Hay JE; Huiatt TW; Lennon VA
Lab Invest; 1992 Mar; 66(3):331-6. PubMed ID: 1538587
[TBL] [Abstract][Full Text] [Related]
6. IgG subclass distribution of ryanodine receptor autoantibodies in patients with myasthenia gravis and thymoma.
Mygland A; Tysnes OB; Aarli JA; Matre R; Gilhus NE
J Autoimmun; 1993 Aug; 6(4):507-15. PubMed ID: 8216692
[TBL] [Abstract][Full Text] [Related]
7. [Determination and clinical significance of serum anti-ryanodine receptor antibody in patients with myasthenia gravis].
Cui LY; Li YF; Li YH; Zhang JB
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Apr; 29(2):238-40. PubMed ID: 17536276
[TBL] [Abstract][Full Text] [Related]
8. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
[TBL] [Abstract][Full Text] [Related]
9. Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies.
Rigamonti A; Lauria G; Piamarta F; Fiumani A; Agostoni E
J Neurol Sci; 2011 Mar; 302(1-2):112-3. PubMed ID: 21236448
[TBL] [Abstract][Full Text] [Related]
10. [Serum anti-titin antibody in patients with myasthenia gravis].
Li YF; Zhang JB; Cui LY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):725-7. PubMed ID: 14714322
[TBL] [Abstract][Full Text] [Related]
11. Three types of striational antibodies in myasthenia gravis.
Suzuki S; Utsugisawa K; Nagane Y; Suzuki N
Autoimmune Dis; 2011; 2011():740583. PubMed ID: 21785709
[TBL] [Abstract][Full Text] [Related]
12. Study of anti-striational and anti-thyroid antibodies in patients with myasthenia gravis.
Cojocaru IM; Cojocaru M; Muşuroi C
Rom J Intern Med; 2000-2001; 38-39():111-20. PubMed ID: 15529579
[TBL] [Abstract][Full Text] [Related]
13. Autoimmunity against the ryanodine receptor in myasthenia gravis.
Skeie GO; Lunde PK; Sejersted OM; Mygland A; Aarli JA; Gilhus NE
Acta Physiol Scand; 2001 Mar; 171(3):379-84. PubMed ID: 11412151
[TBL] [Abstract][Full Text] [Related]
14. Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis.
Mygland A; Aarli JA; Matre R; Gilhus NE
J Neurol Neurosurg Psychiatry; 1994 Jul; 57(7):843-6. PubMed ID: 8021674
[TBL] [Abstract][Full Text] [Related]
15. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies.
Romi F; Skeie GO; Aarli JA; Gilhus NE
Arch Neurol; 2000 Nov; 57(11):1596-600. PubMed ID: 11074791
[TBL] [Abstract][Full Text] [Related]
16. Antimuscle and antiacetylcholine receptor antibodies in myasthenia gravis.
Penn AS; Schotland DL; Lamme S
Muscle Nerve; 1986 Jun; 9(5):407-15. PubMed ID: 3724787
[TBL] [Abstract][Full Text] [Related]
17. Titin and ryanodine receptor autoantibodies in dogs with thymoma and late-onset myasthenia gravis.
Shelton GD; Skeie GO; Kass PH; Aarli JA
Vet Immunol Immunopathol; 2001 Jan; 78(1):97-105. PubMed ID: 11182151
[TBL] [Abstract][Full Text] [Related]
18. Novel autoantibodies to a voltage-gated potassium channel Kv1.4 in a severe form of myasthenia gravis.
Suzuki S; Satoh T; Yasuoka H; Hamaguchi Y; Tanaka K; Kawakami Y; Suzuki N; Kuwana M
J Neuroimmunol; 2005 Dec; 170(1-2):141-9. PubMed ID: 16182377
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune targets of heart and skeletal muscles in myasthenia gravis.
Suzuki S; Utsugisawa K; Yoshikawa H; Motomura M; Matsubara S; Yokoyama K; Nagane Y; Maruta T; Satoh T; Sato H; Kuwana M; Suzuki N
Arch Neurol; 2009 Nov; 66(11):1334-8. PubMed ID: 19752287
[TBL] [Abstract][Full Text] [Related]
20. Muscle autoantibodies in subgroups of myasthenia gravis patients.
Romi F; Skeie GO; Aarli JA; Gilhus NE
J Neurol; 2000 May; 247(5):369-75. PubMed ID: 10896269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
